Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Redfield

Showing results (81-90 of 336) with videos related to

Pageof 34
Sort By:
Military Medicine|February 1, 1987
HTLV-III/LAV infections in the militaryE C Tramont, R Redfield, D Burke, et al.
JAMA|February 8, 2019
Ending the HIV Epidemic: A Plan for the United StatesAnthony S Fauci, Robert R Redfield, George Sigounas, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1990
Isolation of HIV-1 from the blood of seropositive adults: patient stage of illness and sample inoculum size are major determinants of a positive culture. The Walter Reed Retroviral Research GroupD S Burke, A K Fowler, R R Redfield, et al.
Antiviral Research|June 9, 2009
Rapamycin enhances aplaviroc anti-HIV activity: implications for the clinical development of novel CCR5 antagonistsOlga Latinovic, Alonso Heredia, Robert C Gallo, et al.
AIDS Research and Human Retroviruses|February 1, 1989
Patterns of antibody recognition of selected conserved amino acid sequences from the HIV envelope in sera from different stages of HIV infectionA Shafferman, J Lennox, H Grosfeld, et al.
Frontiers in Immunology|February 5, 2026
Transplant center practices that maximize access to living kidney transplantation: the Penn experienceEmre Arpali, Samir Abu-Gazala, Robert R Redfield, et al.
AIDS Research and Human Retroviruses|June 1, 1994
Assessment of gag DNA and genomic RNA in peripheral blood mononuclear cells in HIV-infected patients receiving intervention with a recombinant gp 160 subunit vaccine in a phase I studyM Vahey, D L Birx, N L Michael, et al.
Archives of Dermatology|May 1, 1987
Oral hairy leukoplakia. A distinctive marker of human T-cell lymphotropic virus type III (HTLV-III) infectionG P Lupton, W D James, R R Redfield, et al.
Antiviral Research|December 3, 2014
Binding of fusion protein FLSC IgG1 to CCR5 is enhanced by CCR5 antagonist MaravirocOlga Latinovic, Kate Schneider, Henryk Szmacinski, et al.
AIDS (London, England)|January 23, 2015
Impact of HIV on lung tumorigenesis in an animal modelShigeru Kawabata, Alonso Heredia, Joell Gills, et al.
Pageof 34

Showing results (81-90 of 336) with videos related to

Sort By:
Pageof 34
Military Medicine|February 1, 1987
HTLV-III/LAV infections in the militaryE C Tramont, R Redfield, D Burke, et al.
JAMA|February 8, 2019
Ending the HIV Epidemic: A Plan for the United StatesAnthony S Fauci, Robert R Redfield, George Sigounas, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1990
Isolation of HIV-1 from the blood of seropositive adults: patient stage of illness and sample inoculum size are major determinants of a positive culture. The Walter Reed Retroviral Research GroupD S Burke, A K Fowler, R R Redfield, et al.
Antiviral Research|June 9, 2009
Rapamycin enhances aplaviroc anti-HIV activity: implications for the clinical development of novel CCR5 antagonistsOlga Latinovic, Alonso Heredia, Robert C Gallo, et al.
AIDS Research and Human Retroviruses|February 1, 1989
Patterns of antibody recognition of selected conserved amino acid sequences from the HIV envelope in sera from different stages of HIV infectionA Shafferman, J Lennox, H Grosfeld, et al.
Frontiers in Immunology|February 5, 2026
Transplant center practices that maximize access to living kidney transplantation: the Penn experienceEmre Arpali, Samir Abu-Gazala, Robert R Redfield, et al.
AIDS Research and Human Retroviruses|June 1, 1994
Assessment of gag DNA and genomic RNA in peripheral blood mononuclear cells in HIV-infected patients receiving intervention with a recombinant gp 160 subunit vaccine in a phase I studyM Vahey, D L Birx, N L Michael, et al.
Archives of Dermatology|May 1, 1987
Oral hairy leukoplakia. A distinctive marker of human T-cell lymphotropic virus type III (HTLV-III) infectionG P Lupton, W D James, R R Redfield, et al.
Antiviral Research|December 3, 2014
Binding of fusion protein FLSC IgG1 to CCR5 is enhanced by CCR5 antagonist MaravirocOlga Latinovic, Kate Schneider, Henryk Szmacinski, et al.
AIDS (London, England)|January 23, 2015
Impact of HIV on lung tumorigenesis in an animal modelShigeru Kawabata, Alonso Heredia, Joell Gills, et al.
Pageof 34